ArticleInternational journal of emergency medicine2026
V-A ECMO for refractory malignant arrhythmia and cardiogenic shock following acute hydrofluoric acid burns: a case report and pathophysiology review.
Article in International journal of emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHydrofluoric acid (HF) exposure causes severe systemic toxicity through fluoride ion-mediated electrolyte disturbances, leading to life-threatening cardiovascular complications. While extracorporeal membrane oxygenation (ECMO) has been reported for respiratory failure in HF poisoning, its use for refractory malignant arrhythmias and cardiogenic shock remains extremely rare. CASE PRESENTATION: A 52-year-old male worker sustained extensive HF burns (30% of total body surface area) following an industrial accident. Despite aggressive electrolyte correction and blood purification, he developed refractory ventricular arrhythmias requiring more than 37 defibrillations within 24 h and progressive cardiogenic shock requiring escalating vasopressor support (norepinephrine equivalent up to 1.3 µg/kg/min). On the advice of a multidisciplinary consultation, veno-arterial (V-A) ECMO was successfully implemented, resulting in immediate cessation of malignant arrhythmias and rapid hemodynamic stabilization. The patient was weaned from ECMO after 4 days and discharged home after complete recovery.
conclusionThis case demonstrates the life-saving potential of V-A ECMO in severe HF poisoning complicated by refractory malignant arrhythmias and cardiogenic shock. Early recognition of the need for mechanical circulatory support and timely ECMO implementation may be crucial for survival in such cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.